. . . . . . . "[In comparison with TVR-based strategies, SOF was cost-effective in IL28B CT/TT (ICER per LYG � 22,229) and G1a (� 19,359) patients, not cost-effective in IL28B CC (�45,330), fibrosis F0-F3 (� 26,444), and in cirrhosis (� 34,906) patients, and dominated in G1b patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:19:12+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .